comparemela.com

Latest Breaking News On - Department of immuntechnology at lund university - Page 1 : comparemela.com

Immunovia appoints Philipp Mathieu as Acting CEO

/PRNewswire/ Immunovia AB (publ) announces that Philipp Mathieu has been appointed acting CEO and President with immediate effect. The search for a.

United statesCarl borrebaeckPhilipp mathieuImmunovia incCorporate communicationsDepartment of immuntechnology at lund universityHealth cancer centerDirector investor relationsLund universityCancer centerImmunovia ab

Immunovia AB: Immunovia appoints Philipp Mathieu as Acting CEO

LUND, Sweden, Jan. 20, 2022 /PRNewswire/ Immunovia AB (publ) announces that Philipp Mathieu has been appointed acting CEO and President with immediate effect. The search for a permanent CEO

United statesCarl borrebaeckImmray pancan dPhilipp mathieuImmunovia incCorporate communicationsDepartment of immuntechnology at lund universityHealth cancer centerDirector investor relationsLund universityCancer center

Immunovia s CEO to step down during 2022

/PRNewswire/ Immunovia AB (publ.) announced today that the Company s President and Chief Executive Officer, Patrik Dahlen, has informed the Board of.

United statesCarl borrebaeckPatrik dahlenImmunovia incDepartment of immuntechnology at lund universityHealth cancer centerChief executive officerLund universityCancer centerImmunovia ab

Immunovia AB: Immunovia s CEO to step down during 2022

LUND, Sweden, Nov. 30, 2021 /PRNewswire/ Immunovia AB (publ.) announced today that the Company's President and Chief Executive Officer, Patrik Dahlen, has informed the Board of Directors

United statesCarl borrebaeckImmray pancan dPatrik dahlenImmunovia incDepartment of immuntechnology at lund universityHealth cancer centerChief executive officerLund universityCancer center

Immunovia s CEO to step down during 2022

/PRNewswire/ Immunovia AB (publ.) announced today that the Company s President and Chief Executive Officer, Patrik Dahlen, has informed the Board of.

United statesCarl borrebaeckPatrik dahlenImmunovia incDepartment of immuntechnology at lund universityHealth cancer centerChief executive officerLund universityCancer centerImmunovia ab

vimarsana © 2020. All Rights Reserved.